These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1294735

  • 1. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
    Pincus T, Marcum SB, Callahan LF.
    J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
    [Abstract] [Full Text] [Related]

  • 2. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T, Callahan LF.
    Agents Actions Suppl; 1993 Dec; 44():67-75. PubMed ID: 8103964
    [Abstract] [Full Text] [Related]

  • 3. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs.
    Pincus T, Marcum SB, Callahan LF, Adams RF, Barber J, Barth WF, Gordon GV, Huston JW, Polk JR, Whelton JC.
    J Rheumatol; 1992 Dec; 19(12):1874-84. PubMed ID: 1294734
    [Abstract] [Full Text] [Related]

  • 4. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T, Pincus T.
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [Abstract] [Full Text] [Related]

  • 7. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
    Criswell LA, Such CL, Yelin EH.
    J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA.
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [Abstract] [Full Text] [Related]

  • 9. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO, Ward JR.
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
    Galindo-Rodriguez G, Aviña-Zubieta JA, Russell AS, Suarez-Almazor ME.
    J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
    [Abstract] [Full Text] [Related]

  • 14. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A, LeClerq SA, Russell AS, Suarez-Almazor ME.
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [Abstract] [Full Text] [Related]

  • 15. Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.
    Papadopoulos NG, Alamanos Y, Papadopoulos IA, Tsifetaki N, Voulgari PV, Drosos AA.
    J Rheumatol; 2002 Feb; 29(2):261-6. PubMed ID: 11838843
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS.
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [Abstract] [Full Text] [Related]

  • 18. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM.
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE, Bochkova AG, Bunchuk NV.
    Ter Arkh; 2008 Dec; 80(5):25-30. PubMed ID: 18590110
    [Abstract] [Full Text] [Related]

  • 20. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H, Burkhardt H.
    Fortschr Med; 1983 Apr 14; 101(14):639-45. PubMed ID: 6406333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.